Use of recombinant factor VIIa in patients with amniotic fluid embolism.

Παρόμοια τεκμήρια

• Incidence and risk factors for amniotic-fluid embolism
  ανά: Knight, M, κ.ά.
  Έκδοση: (2010)
• Incidence and risk factors for amniotic-fluid embolism.
  ανά: Knight, M, κ.ά.
  Έκδοση: (2010)
• Amniotic fluid embolism - an update.
  ανά: Tuffnell, D, κ.ά.
  Έκδοση: (2011)
• Incidence and Risk Factors for Amniotic-Fluid Embolism EDITORIAL COMMENT
  ανά: Knight, M, κ.ά.
  Έκδοση: (2010)
• Low-dose recombinant factor VIIa for massive bleeding
  ανά: A Mordasini, κ.ά.
  Έκδοση: (2011-07-01)